Ahmed M. Altibi, MD, MPH
Clinical FellowAbout
Research
Publications
2025
Predictors of discontinuation and non-publication of heart failure clinical trials: A cross-sectional analysis of ClinicalTrials.gov data
Alawajneh M, Aljabali A, Theeb L, Tashtoush S, Alshwayyat S, Mostafa A, Alhuneafat L, Laudani C, Altibi A. Predictors of discontinuation and non-publication of heart failure clinical trials: A cross-sectional analysis of ClinicalTrials.gov data. International Journal Of Cardiology 2025, 442: 133901. PMID: 40953737, DOI: 10.1016/j.ijcard.2025.133901.Peer-Reviewed Original ResearchCross-sectional analysisHF trialsPredictor of trial completionHeart failureTrial completionClinical trialsHeart failure clinical trialsPublic health challengeHF clinical trialsPredictors of discontinuationPublication statusLikelihood of discontinuationIntervention typeHealth challengesBehavioral interventionsLogistic regressionRandomized trialsFunding sourcesClinical researchTrialsInterventionTrial phaseFrequent discontinuationNon-publicationStatusShort-term outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve: insights from nationwide readmission analysis
Alhuneafat L, Ghanem F, Obeidat O, Alzyoud A, Ma’aita A, Ajam M, Altibi A. Short-term outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve: insights from nationwide readmission analysis. Cardiovascular Intervention And Therapeutics 2025, 40: 921-931. PMID: 40676444, DOI: 10.1007/s12928-025-01173-y.Peer-Reviewed Original ResearchConceptsBicuspid aortic valveTranscatheter aortic valve implantationBicuspid aortic valve patientsTranscatheter aortic valve implantation patientsPropensity-score matchingShort-term outcomesIn-Hospital MortalityAortic valve implantationTAV patientsMatched CohortShort-term outcomes of transcatheter aortic valve implantationAortic valveValve implantationOutcomes of transcatheter aortic valve implantationIn-hospital complication ratesSevere aortic stenosisReadmission ratesAcute kidney injuryLong-term outcomesTranscatheter aortic valve implantation outcomesNationwide Readmissions DatabaseComplication rateAortic stenosisKidney injuryCardiovascular Hospitalizations Burden Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
Altibi A, Elman M, Volk H, Alqabani M, Butzner M, Song H, Masri A. Cardiovascular Hospitalizations Burden Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Journal Of The American Heart Association 2025, 14: e040655. PMID: 40654254, PMCID: PMC12533672, DOI: 10.1161/jaha.124.040655.Peer-Reviewed Original ResearchConceptsObstructive hypertrophic cardiomyopathySeptal myectomyHypertrophic cardiomyopathyCardiovascular hospitalizationPost-SMYears median follow-upAdvanced heart failure therapiesMedian Follow-UpVentricular septal defectHeart failure therapyChronic obstructive pulmonary diseaseChronic kidney diseaseHealth claims databaseImplantable cardioverter-defibrillatorObstructive pulmonary diseaseSeptal defectFailure therapyAtrial fibrillation/flutterAdult patientsVentricular arrhythmiasCardiac arrestFollow-upCardioverter-defibrillatorCardiomyopathyPrimary outcomeThe burden of cardiovascular disease in Latin America and the Caribbean, 1990-2019: An analysis of the global burden of disease study
Alhuneafat L, Al Ta'ani O, Arriola-Montenegro J, Al-Ajloun Y, Naser A, Chaponan-Lavalle A, Ordaya-Gonzales K, Pertuz G, Maaita A, Jabri A, Altibi A, Al-Abdouh A, Van't Hof J, Gutierrez Bernal A. The burden of cardiovascular disease in Latin America and the Caribbean, 1990-2019: An analysis of the global burden of disease study. International Journal Of Cardiology 2025, 428: 133143. PMID: 40064205, DOI: 10.1016/j.ijcard.2025.133143.Peer-Reviewed Original ResearchConceptsDisability-adjusted life yearsGlobal Burden of DiseaseBurden of cardiovascular diseaseCardiovascular diseaseRisk factorsMortality-to-incidence ratioGlobal burdenIschemic heart diseaseAge-standardized disability-adjusted life yearsGlobal Burden of Disease StudyDisability-adjusted life year ratesBurden of Disease StudyAge-standardized prevalenceComparative risk assessment frameworkCardiovascular disease prevalenceCardiovascular disease burdenBurden of diseaseLeading risk factorHeart diseaseTailored interventionsCountry-specific variationsElevated BMIRate of strokeHealthcare infrastructureSocio-economic factorsThe comparative efficacy and safety of Tiger II versus judkins catheters in coronary angiogram via the radial artery access: a meta-analysis
Aljabali A, Alawajneh M, Hammad A, Nguyen D, Alkasabrah A, Abuein K, Altibi A. The comparative efficacy and safety of Tiger II versus judkins catheters in coronary angiogram via the radial artery access: a meta-analysis. Acta Cardiologica 2025, 80: 39-43. PMID: 39781598, DOI: 10.1080/00015385.2024.2442799.Peer-Reviewed Original ResearchConceptsStandardised mean differenceFluoroscopy timeContrast volumeProcedure timeJudkins catheterOdds ratioProcedural successCoronary angiogramTiger IIEstimates of odds ratiosRadiation exposureMeta-analysisReduced fluoroscopy timeRadial artery vasospasmRandom-effects modelWeb of ScienceRadial artery accessComplication rateArtery vasospasmSecondary outcomesPrimary outcomeComparative efficacyArterial accessTransfemoral accessCochrane LibraryCoronary Aneurysms in Polyarteritis Nodosa
Altibi A, Alsamhori J, Khan A. Coronary Aneurysms in Polyarteritis Nodosa. JAP Academy Journal 2025, 3: 63-64. DOI: 10.4103/japaj.japaj_6_24.Peer-Reviewed Original Research
2024
Factors associated with non-publication of clinical trials in cardiovascular medicine: a cross-sectional analysis
Alawajneh M, Aljabai A, Theeb L, Badwan Z, Alnabi A, Theeb H, Altibi A. Factors associated with non-publication of clinical trials in cardiovascular medicine: a cross-sectional analysis. European Heart Journal 2024, 45: ehae666.3639. DOI: 10.1093/eurheartj/ehae666.3639.Peer-Reviewed Original ResearchCross-sectional analysisClinical trialsIntervention typeLogistic regressionCardiovascular medicineNon-randomised trialsOpen-label trialPublication statusMultivariate logistic regressionArea of clinical researchEnrollment sizeNon-publicationCardiovascular clinical trialsCardiovascular-relatedParticipant ageTriple-blindTrial completionDecreased likelihoodRandomised trialsTrial publicationsPredictor factorsFunding sourcesResearch fundingClinical researchEnrollmentEditorial: Unveiling the clinical implications of left atrial remodeling assessment methods
Khalouf A, Abuzaid A, Altibi A. Editorial: Unveiling the clinical implications of left atrial remodeling assessment methods. International Journal Of Cardiology 2024, 418: 132575. PMID: 39313119, DOI: 10.1016/j.ijcard.2024.132575.Peer-Reviewed Original ResearchRacial, ethnic and sex disparity in acute heart failure patients with COVID-19: A nationwide analysis
Hashem A, Khalouf A, Mohamed M, Nayfeh T, Elkhapery A, Zahid S, Altibi A, Thyagaturu H, Kashou A, Anavekar N, Gulati M, Balla S. Racial, ethnic and sex disparity in acute heart failure patients with COVID-19: A nationwide analysis. Heliyon 2024, 10: e34513. PMID: 39157311, PMCID: PMC11327804, DOI: 10.1016/j.heliyon.2024.e34513.Peer-Reviewed Original ResearchAcute heart failureImpact of raceNational Inpatient SampleCOVID-19 infectionWhite malesHispanic malesDiagnosis of acute heart failureOutcomes of acute heart failureOdds of cardiac arrestAcute heart failure patientsCOVID-19Sex disparitiesWhite femalesOdds of in-hospital mortalityEthnicityRaceDisparitiesMultivariate logistic regression modelIn-Hospital MortalityIn-Hospital OutcomesHeart failure patientsLogistic regression modelsHispanic ethnicityHeart failureCardiac arrestOutcomes of Adult Patients With COVID-19 Transitioning From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation in the Extracorporeal Life Support Organization Registry
Nguyen K, Altibi A, Prasad P, Mukundan S, Shekar K, Ramanathan K, Zakhary B. Outcomes of Adult Patients With COVID-19 Transitioning From Venovenous to Venoarterial or Hybrid Extracorporeal Membrane Oxygenation in the Extracorporeal Life Support Organization Registry. ASAIO Journal 2024, 70: 1040-1045. PMID: 38810234, DOI: 10.1097/mat.0000000000002243.Peer-Reviewed Original ResearchExtracorporeal membrane oxygenationVv-extracorporeal membrane oxygenationVenovenous extracorporeal membrane oxygenationExtracorporeal Life Support OrganizationMembrane oxygenationAdult patientsTreated with VV ECMOExtracorporeal Life Support Organization registryOutcomes of adult patientsFactors associated with conversionRisk factors associated with conversionIn-hospital mortality rateExtracorporeal membrane oxygenation configurationRenal replacement therapyLife Support OrganizationIn-Hospital MortalityPrimary outcome measureRisk of mortalityRisk of conversionCOVID-19 patientsInotrope requirementPre-ECMOPropensity score matchingVA-ECMOInotropic agents